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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARYStrategies for improved homing of mesenchymal stem cells (MSCs) to a place of injury are being sought and it has been shown that nat-
ural killer (NK) cells can stimulate MSC recruitment. Here, we studied the chemokines behind this recruitment. Assays were performed
with bonemarrowhumanMSCs andNK cells freshly isolated fromhealthy donor buffy coats. Supernatants fromMSC-NK cell co-cultures
can induce MSC recruitment but not to the same extent as when NK cells are present. Antibody arrays and ELISA assays confirmed that
NK cells secrete RANTES (CCL5) and revealed that humanNK cells secrete NAP-2 (CXCL7), a chemokine that can induceMSCmigration.
Inhibition with specific antagonists of CXCR2, a receptor that recognizes NAP-2, abolished NK cell-mediated MSC recruitment. This
capacity of NK cells to produce chemokines that stimulateMSC recruitment points toward a role for this immune cell population in regu-
lating tissue repair/regeneration.INTRODUCTION
Mesenchymal stem/stromal cells (MSCs) are attractive for
different cell-based therapies, from bone regeneration to
treatment of autoimmune diseases (Singer and Caplan,
2011). However, tissue regeneration therapies that involve
injection/implantation of MSCs have not been fully suc-
cessful, and strategies that use soluble mediators produced
byMSCs or that attract endogenous stem cells and regulate
its behavior are appealing, as recruitment, and not only
proliferation and differentiation of progenitor cells, is
important for effective repair/regeneration (Wei et al.,
2013). In this context, it is important to know which fac-
tors regulate MSC recruitment.
Mobilization and recruitment of MSCs to a bone injury
has been correlated with repair (Granero-Molto et al.,
2009; Kumar and Ponnazhagan, 2012). Inflammatory
mediators can lead to increased MSC migration (Ren
et al., 2010; Tondreau et al., 2009), and thus immune
cells such as macrophages and natural killer (NK) cells
can stimulate MSC recruitment (Almeida et al., 2012;
Anton et al., 2012). While monocytes/macrophages
can also stimulate MSC differentiation along the osteo-
blastic lineage (Champagne et al., 2002; Ekstrom et al.,
2013), NK cells do not interfere with MSC differentiation
capacity (Almeida et al., 2012). This may be of interest
as cell differentiation into specific lineages can then be
orchestrated by other cues from the microenvironment.
Macrophages can recruit MSC by producing the chemo-
kine RANTES (Anton et al., 2012), which is involved
in recruitment of MSCs in the degenerated interverte-466 Stem Cell Reports j Vol. 6 j 466–473 j April 12, 2016 j ª2016 The Authobral disc (Pattappa et al., 2014). However, the chemo-
kines behind NK cell-mediated MSC recruitment are still
unknown.
NK cells are one of the first immune cell populations to
arrive at an injury site (Agaiby and Dyson, 1999), are
involved in uterine tissue remodeling in pregnancy (Mof-
fett and Colucci, 2014), may contribute to wound healing
(Liippo et al., 2009), and can trigger differentiation of
monocytes into osteoclasts (Soderstrom et al., 2010). NK
cells are capable of recognizing cells in different stages of
the cell cycle (Nolte-’t Hoen et al., 2006), and their activa-
tion by target cells depends on the target cells activating/
inhibitory ligands ratio and distribution in the cell mem-
brane (Almeida and Davis, 2006; Endt et al., 2007; Kaplan
et al., 2011). Activation of NK cells by different ligands or
in different contexts may lead to degranulation of lytic
granules, or cytokine or chemokine secretion (Almeida
et al., 2011; Fauriat et al., 2010). NK cells produce several
chemokines (Fauriat et al., 2010; Robertson, 2002), which
can stimulate MSC recruitment (Anton et al., 2012; Ponte
et al., 2007).
In this work, we dissected some of the chemokines
involved in NK-cell-mediated MSC recruitment, focusing
on NAP-2, GRO-b, GRO-g, interleukin-8 (IL-8), and
RANTES. Resting human NK cells can produce different
soluble factors that may play a role in this recruit-
ment. Of significance is secretion of NAP-2, which can
stimulate MSC migration on its own. Furthermore,
treating MSCs with an antagonist specific for the
chemokine receptor CXCR2 abolished MSC recruitment
by NK cells.rs
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Figure 1. Characterization of Chemo-
kines Involved in NK-Cell-Mediated MSC
Recruitment
(A and B) MSC invasion through filters
coated with Matrigel was determined after
24 hr of incubation. (A) The lower
compartment of the invasion chamber was
filled with serum-free medium, as a negative
control, or with NK cells. MSCs were either
untreated (control) or pre-treated with
pertussis toxin at 100 ng/ml for 2 hr at
37C/5% CO2 (n = 6 independent experi-
ments with four NK cell and two MSC donors,
*p < 0.05; Wilcoxon test). (B) The lower
compartment was filled with serum-free
medium, NK cells, or with supernatants
(sup) from MSCs or NK cells cultured alone
or collected after an invasion assay. n = 6–9
independent experiments with six NK cell
and three MSC donors, *p < 0.05;
***p < 0.001; Kruskal-Wallis test followed
by the Dunn’s multiple comparisons test to
compare each sample against the negative
control.
(C) The supernatants were analyzed with
protein arrays detecting 38 different fac-
tors. Examples of the developed membranes
with indication of factors of interest.
(D) Concentrationsof RANTES,GRO-b, GRO-g,
NAP-2, and IL-8 in supernatants of NK cells,
MSCs, or NK cells co-cultured with MSCs in
invasion assays were determined by ELISA.
Graphs are min-max whisker plots. n = 10
independent experiments with ten NK cell
and three MSC donors; *p < 0.05; ***p <
0.001; Friedman test followed by Dunn’s
multiple comparisons test to compare each
sample against the negative control.
(E) Intracellular staining of NAP-2 (bottom)
was performed on isolated NK cells (CD56+/
CD3, top). Plots are representative of data
from four NK cell donors.RESULTS AND DISCUSSION
NK Cells Produce Soluble Mediators that Stimulate
MSC Invasion
NK cells stimulate MSC invasion through transwell cham-
bers coated with Matrigel, which mimics the extracellular
matrix. In order to dissect regulation of MSC recruitment,
invasion assays were performed with MSCs pre-treated
with pertussis toxin, which inhibits all G-coupled pro-
teins, including chemokine receptors and others. NK-cell-
mediated MSC recruitment was inhibited in the presence
of pertussis toxin (Figure 1A). As NK cells are known
producers of chemokines, which are usually involved inStemrecruitment of cells in an inflammatory context, this sug-
gests chemokines receptors may have a role in NK-cell-
mediated MSC recruitment.
Invasion assays were performed with MSCs stimulated
with NK cells or conditionedmedia collected fromNK cells
andMSCs alone or in co-culture. The number of MSCs that
invaded through theMatrigel coating increased in the pres-
ence of media from co-cultures but not as much as in the
presence of NK cells (Figure 1B). This indicates that NK cells
continuously produce soluble factors that promote MSC
invasion, which in the case of the supernatants will be
consumed without being replenished. The fact that only
conditionedmedia from co-cultures had a significant effectCell Reports j Vol. 6 j 466–473 j April 12, 2016 j ª2016 The Authors 467
suggests that either MSCs also produce mediators that
promote its own recruitment and/or that MSCs further
stimulate NK cells to produce the factors involved in this
recruitment.
The overall number of MSCs being recruited by NK cells
might seem low, but it represents a fold increase higher
than three. In these invasion assays, cells have to remodel
the matrix to cross the transwell, and thus the number of
cells that cross the membrane will be lower than in migra-
tion assays, with uncoated membranes. The number of
recruited cells might increase when there are more NK cells
as a stimulus (Almeida et al., 2012) or when NK cells are
stimulated to produce higher amounts of mediators.
NK Cells Secrete Chemokines Such as NAP-2
To find chemokines thatmight be stimulatingMSC recruit-
ment, supernatants from MSC, NK cells, or co-cultures
were analyzed with antibody arrays. NK cells and MSCs
secreted different chemokines, including the yet unde-
scribed NAP-2 for NK cells and GRO for MSCs (Figure 1C).
Other chemokines that have been reported to have a role
in regulating MSC recruitment, such as SDF-1, MIP-1a,
MIP-1b, and MCP-1 (Eseonu and De Bari, 2015), were not
consistently detected for all donors analyzed and thus
were not further pursued.
With three independent NK cell donors, semi-quantita-
tive analysis revealed a decrease in the amount of NAP-2
and RANTES and an increase in the amount of GRO (but
not GRO-a) in the co-culture, compared with the sum of
the amounts produced by NK cells and MSCs separately
(Figure S1). IL-8 is a cytokine known to promote MSC
recruitment (Anton et al., 2012) that was secreted at very
high levels by MSCs and whose increase or decrease in the
co-culture varied. Therefore, ELISA assays were performed
for quantification of RANTES, GRO-b, GRO-g, NAP-2, and
IL-8 (Figure 1D). Importantly, NK cells from all donors
secreted significant amounts of NAP-2, with a slight in-
crease in the presence of MSCs. This is in agreement with
the increased recruitment of MSCs by supernatants from
MSC-NK cell co-cultures, and strengthens the need to
confirm data obtained by antibody arrays. NAP-2 is a che-
mokine produced by platelets that stimulates recruitment
and activation of neutrophils and has never been reported
to be produced by NK cells. Intracellular staining against
NAP-2 on freshly isolated NK cells from four donors
confirmed that 27.3% ± 7.6% of CD56+ cells expressed
NAP-2 (Figure 1E). RANTES and IL-8 have been described
to be involved in macrophage-mediated MSC recruitment
(Anton et al., 2012). Here, it was confirmed that NK cells
secrete RANTES, producing a lower amount in the presence
of MSCs. The amount of secreted IL-8 increased signifi-
cantly in the MSC-NK cell co-cultures. This suggests that
RANTES is being consumed in the co-culture while pro-468 Stem Cell Reports j Vol. 6 j 466–473 j April 12, 2016 j ª2016 The Authoduction of IL-8 is being further stimulated. No statistically
significant differences were found for the other mediators.
NAP-2 Can Promote MSC Migration
To clarify the role of chemokines, which are expected to
stimulate cell migration but not matrix remodeling, migra-
tion assays were performed, with chambers that were not
coated with Matrigel, instead of the more physiological in-
vasion assays. MSCmigration was tested with recombinant
human RANTES, GRO-b, GRO-g, NAP-2, IL-8, or all these
factors combined. As in migration assays, cells do not
have to remodel a matrix; recruitment occurs with a faster
kinetics and thus chambers were incubated for 6 hr as
opposed to the 24 hr necessary to analyze invasion.
Data showed that GRO-g at 1 ng/ml and NAP-2 at
10 ng/ml stimulated MSC recruitment (Figure 2). Others
have shown that high doses of NAP-2 can also stimulate
MSC recruitment and that treatment with these doses leads
to increased production of other chemokines, including
all the ones that bind to CXCR2, the receptor for NAP-2
(Kalwitz et al., 2009).
All other factors analyzed showed a tendency to stimulate
MSC migration, but to levels that were not statistically sig-
nificant. A characteristic bell-shaped response curve could
be observed with GRO-g and IL-8. It has been reported
that both RANTES and IL-8 stimulate MSC migration, but
for 18 hr migration assays performed in the presence of
10% fetal bovine serum (FBS) (Anton et al., 2012). Here ex-
periments were performed without serum as it is capable
on its own of stimulating migration, and may thus mask
the effect that NK cells have on MSC recruitment. When
combining all proteins, there was a slight but not statis-
tically significant increase in the number of MSCs that
migrated. It can be speculated that, when combining all
the proteins together, an equilibriumbetween chemoattrac-
tants and chemorepellents is reached. Chemokines at high
concentrations can become chemorepellent, and fugetaxis,
themovement of leukocytes away fromchemotactic agents,
has been described (Vianello et al., 2005). When testing the
recombinant proteins on their own, it was clear that NAP-2
induced migration at the higher concentration of 10 ng/ml
andGRO-g only at the lower concentration of 1 ng/ml,with
a decrease in migration for higher concentrations. As these
chemokines can bind to the same receptor, it is possible
that the amount of chemokine binding to CXCR2 is such
that there is no chemoattraction. Thus, the effect of NAP-2
might depend on the microenvironment (and the other
chemokines) the cells will encounter.
Blocking CXCR2 Abolishes NK-Cell-Mediated MSC
Recruitment
Table 1 summarizes the published data on MSC expression
of chemokine receptors for the chemokines analyzed here.rs
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Figure 2. Number of MSC Migrating when
Stimulated with Recombinant Human
RANTES, GRO-b, GRO-g, NAP-2, IL-8, or
a Combination of All These Chemokines
A migration assay was performed with an
uncoated transwell for 6 hr when MSCs were
stimulated with 1 or 10 ng/ml of recombi-
nant proteins. Graphs are min-max whisker
plots. n = 5–7 independent experiments
with three MSC donors; *p < 0.05; data were
compared with the Friedman test followed
by Dunn’s multiple comparisons test.Contradictory results on expression of the chemokine re-
ceptors CCR1, CCR3, CCR5, CXCR1, and CXCR2 may be
due to differences in isolation techniques, culture condi-
tions, harvesting protocols, methods used for detection of
these molecules, or even in differences between donors.
But interestingly, GRO-b, GRO-g, NAP-2, IL-8 can all be
recognized by the chemokine receptor CXCR2, whose
expression on MSCs has been described (Kalwitz et al.,
2009; Ringe et al., 2007) and confirmed here by imaging
flow cytometry and immunocytochemistry (Figure S2).
Therefore, invasion assays were performed with MSCs
treated with a CXCR2 antagonist, SB225002 (Figure 3A).
It was found that inhibiting CXCR2 abolished NK-cell-
mediated MSC recruitment.
Here, it was shown that freshly isolated primary NK cells
can produce NAP-2. In an injury scenario, NK cells will be
recruited and if reaching a sufficiently high number of
cells, they might establish an NAP-2 gradient. It is not clear
whether NK cells in an injury/inflammation site become
activated as the cytokines that are well known to activate
NK cells (IL-2, IL-15, IL-18, and IL-12) are not common at
an injury site. However, cytokines characteristic of tissue
repair such as tumor necrosis factor alpha (TNF-a), IL-6,
and IL-1, can affect NK cell maturation, differentiation,
cytotoxicity, and cytokine secretion (Cooper et al., 2001;
Lee et al., 2009; Passos et al., 2010). NK cells can alsoStembecome activated to secrete chemokines by binding to
different ligands (Fauriat et al., 2010). Thus, future stra-
tegies encompassing biomaterials that either stimulate
NAP-2 production or that arrest NK cells to function as
factories of chemokines will be of interest.
To conclude, here we propose that NAP-2 secreted by
human NK cells can bind to CXCR2 on MSCs leading to
stimulation of its recruitment (Figure 3B). Besides NAP-2,
other chemokines that bind to CXCR2 can be produced
by NK cells, albeit to different extents by different donors.
NK cells can also produce RANTES, which may also have a
role in mediating MSC recruitment. The fact that NK cells
isolated from different donors produce different CXCR2-
binding chemokines suggests that CXCR2 may be a key
chemokine receptor.EXPERIMENTAL PROCEDURES
MSC and NK Cell Isolation
MSCs and NK cells were isolated as described elsewhere (Almeida
et al., 2012). All experimental protocols were conducted following
the approval and recommendations of the Ethics Committee for
Health from Centro Hospitalar S. Joa˜o. MSCs were isolated from
human bone marrow samples collected by Servic¸o de Ortopedia
e Traumatologia from Hospital de Sa˜o Joa˜o after ethics committee
approval and informed consent. Isolation of MSCs was confirmedCell Reports j Vol. 6 j 466–473 j April 12, 2016 j ª2016 The Authors 469
Table 1. Summary of Published Data on Human Bone Marrow MSC Expression of Chemokine Receptors that Recognize the
Chemokines that Were Analyzed
Chemokine Other Names Receptor Expression of Receptors by MSCs
RANTES CCL5 CCR1, CCR3, CCR5 No expression of CCR1, while CCR3 and CCR5 expression increase after TNF-a
stimulation (Hemeda et al., 2010; Ponte et al., 2007); only CCR3 detected,
expression increases after TNF-a and interferon-g stimulation (Croitoru-Lamoury
et al., 2007); positive for CCR1, negative for CCR3 and CCR5 (Honczarenko et al.,
2006); positive for intracellular CCR1 and CCR3 and negative for CCR5 expression
(Brooke et al., 2008); small percentage expresses CCR1, no mRNA detected for CCR3
or CCR5 (Sordi et al., 2005); positive for CCR1 and CCR3 (Djouad et al., 2007)
GRO-b CXCL2, MIP-2a CXCR2 No expression (Honczarenko et al., 2006; Ponte et al., 2007; Sordi et al., 2005);
MSCs positive for both CXCR2 and CXCR1 (Kalwitz et al., 2009; Ringe et al., 2007)
GRO-g CXCL3, MIP-2b CXCR2
NAP-2 CXCL7 CXCR2
IL-8 CXCL8 CXCR1, CXCR2by surface staining of CD105, CD73, CD90, CD45, CD34, CD14,
CD19, and HLA-DR and by testing differentiation in osteoblasts,
chondroblasts, or adipocytes (Almeida et al., 2012). Prior to each
experiment, frozen aliquots of MSCs were thawed and cultured
in DMEM with low glucose and with Glutamax plus 10% selected
inactivated FBS and 1% penicillin/streptomycin (all from Invitro-
gen). After reaching about 80% confluence, cells were detached
with 0.05% trypsin/EDTA. Experiments were performed with
MSCs from four donors, in passages 6–8.
NK cells were obtained from human healthy donors buffy coats,
kindly provided by Hospital de Sa˜o Joa˜o. Briefly, a peripheral blood
mononuclear cell suspension was prepared by density gradient
centrifugation, and NK cells were purified by negative selection
using the EasySep human NK cell enrichment kit (STEMCELL
Technologies), according to the manufacturer’s instructions. The
percentage of CD56+/CD3- cells was higher than 80% (average
90%). NK cells were isolated from 12 different donors.
Migration and Invasion Assays
Studies on migration and invasion of MSCs were performed using
a transwell chamber system. Membrane filters with a pore size of
8 mm were used, and coated with Matrigel (Corning) for invasion
assays. For migration assays, the top chamber was incubated with
100 ml of bovine gelatin 0.1% for 1 hr at 37C/5% CO2 and
washed with PBS to promote cell adhesion. For invasion assays,
Matrigel-coated inserts were pre-incubated for 1 hr with serum-
free DMEM. The lower compartments of the chamber were
filled with 750 ml of DMEM medium, as a negative control, or
serum-free DMEM with NK cells at an NK/MSC ratio of 15:1.
MSCs (4 3 104 cells per well) in 500 ml of serum-free DMEM
medium were seeded into the upper compartment. Migration
and invasion chambers were incubated at 37C/5% CO2 for
6 hr and 24 hr, respectively. After incubation, inserts were
washed with PBS and cells were fixed in 4% paraformaldehyde for
15 min at room temperature (RT). Supernatants from invasion
assays were spun at 300 3 g for 10 min, collected, and frozen
at 80C for other assays. Inserts were washed with PBS and
kept at 4C until analysis. Cells on the top surfaces of the fil-
ters were wiped off with cotton swabs, and the membrane was470 Stem Cell Reports j Vol. 6 j 466–473 j April 12, 2016 j ª2016 The Authomounted in a slide with Vectashield and DAPI. Cells that had
migrated and attached to the lower surface of the filter were
counted in a fluorescence microscope (Zeiss Axiovert). Cell nuclei
were counted in ten 2003 fields of view for each membrane. The
number of migrated cells was estimated by taking into account
the area of a field of view and the total area of the membrane.
Assays with supernatants were performed by adding 750 ml of
collected supernatant to the bottom well. When specified, MSCs
were pre-treated with pertussis toxin at 100 ng/ml for 2 hr at
37C/5% CO2, harvested, and added to the invasion chambers.
Migration assays with recombinant proteins were performed
with 1 or 10 ng/ml RANTES, GRO-b, GRO-g, NAP-2, or IL-8 (Pepro-
tech). For treatment with antagonist, MSCs were pre-incubated
with 0.13 mM SB225002 (Sigma) for 1 hr in the invasion chamber.
Controls were performed with the vehicle DMSO.Protein Arrays
The presence of different chemokines was analyzed in super-
natants collected from invasion assays with the human chemo-
kine antibody array 1 (RayBiotech) following the manufacturer’s
instructions.ELISA Assays
ELISA kits were used to quantify RANTES (RayBiotech), NAP-2
(RayBiotech), and IL-8 (BioLegend). For GRO-b and GRO-g, plates
were incubated at 4C with agitation for 24 hr with 100 ml of
serially diluted standard in PBS or samples. Plates were washed
four times with 300 ml of wash buffer (0.05% Tween 20 in PBS)
per well and blocked for 2 hr at RT with 300 ml of blocking
buffer (1% BSA, BSA, in PBS). Plates were washed prior to adding
1 mg/ml biotinylated anti-GRO-b (rabbit IgG) or anti-GRO-g
(rabbit IgG) antibodies (both from Peprotech) in 0.05% Tween
20/0.1% BSA in PBS. Plates were incubated for 2 hr and washed.
Then, 100 ml of avidin-horseradish peroxidase conjugate (1:2,000)
was added, and plates were incubated for 30 min at RT. Plates
were washed and 100 ml of substrate solution (1 mg/ml o-phenyl-
enediamine dihydrochloride with 0.03% H2O2 in phosphate
citrate buffer 0.05 M [pH 5.0]) was added. Plates were incubatedrs
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Figure 3. NK-Cell-Mediated MSC Recruitment Involves the
Chemokine Receptor CXCR2
(A) MSCs were treated for 1 hr with 0.13 mM of the CXCR2 antagonist
SB225002 before performing a 24 hr invasion assay through Ma-
trigel-coated transwells when stimulated with medium only or with
NK cells. The chemotactic index is calculated by dividing the
number of MSCs migrating when stimulated with NK cells by the
negative control. Graphs are min-max whisker plots. n = 8 inde-
pendent experiments with eight NK cell and two MSC donors; *p <
0.05; **p < 0.01; Kruskal-Wallis test followed by Dunn’s multiple
comparisons test to compare all samples.
(B) Resting human NK cells produce NAP-2, which stimulates MSC
recruitment via CXCR2. Furthermore, NK cells are capable of pro-
ducing other chemokines that can bind to CXCR2, such as GRO-b,
GRO-g, and IL-8. NK cells also produce RANTES, which might be
recognized by CCR1, CCR3, or CCR5. On the other hand, MSCs seem to
produce unknown paracrine factors that affect NK cells and thus
affect stimulation of MSC recruitment.at RT for color development and 100 ml of H2SO4 1 M was added.
Plates were read at 492 nm with wavelength correction at
630 nm.NAP-2 Intracellular Staining
NK cells were cultured at 106 cells/ml for 5 hr at 37C/5% CO2
with 10 mg/ml brefeldin A (Sigma). Then, cells were collected
and fixed with paraformaldehyde 4% for 15 min at RT, washed,
and permeabilized with 0.5% BSA/0.2% Tween/PBS on ice for
15 min. Cells were incubated with 10 mg/ml anti-human NAP-2
antibody (# 59418, R&D Systems) in 0.5% BSA/0.2% Tween/PBS
for 1 hr on ice. Cells were washed before incubating with anti-
mouse Alexa Fluor 647 antibody (1:500; Invitrogen) for 45 min
and washed again. Cells were then stained with anti-CD56-PE
(AF12-7H3, Miltenyi Biotec) and anti-CD3-FITC (MEM-57, Immu-
notools) on ice for 30 min. Cells were washed and 10,000 events
were acquired in a Flow Cytometer (FACSCanto II; Becton Dickin-
son) and analyzed with FlowJo. Appropriate isotype controls were
used.StemStatistical Analysis
After verifying that the data did not follow a normal distribution,
differences between samples were determined with the Wilcoxon,
Kruskal-Wallis, and Friedman non-parametric tests. TheWilcoxon
test was performed to compare two related samples; the Kruskal-
Wallis and Friedman tests were used when there were more than
two conditions to compare unpaired and paired data, respec-
tively, and were followed by the Dunn’s multiple comparisons
test. Statistical analyses were performed with GraphPad Prism 5
for Windows.
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